Eric advises life sciences clients in the areas of new product planning, launch planning, competitive strategy and pricing, reimbursement and market access. His clients include both leading and emerging manufacturers of innovative and established biopharmaceuticals, vaccines, medical devices, clinical diagnostics, and animal health products. Eric’s specialty is advising on competitive strategy, helping clients to evaluate
Domenick advises biopharmaceutical, diagnostic, medical device, VC and private equity clients on new product strategies, therapeutic area strategies (including L&D), growth strategies, franchise strategic marketing, and pricing and market access. He specializes in studies that leverage quantitative analysis, deep understanding of healthcare stakeholders, and sophisticated modeling, often involving primary research. He has supported commercialization of
Paul advises biopharmaceutical and medical device clients on growth strategies, new product strategy, franchise strategic marketing, and pricing and reimbursement. He also serves as co-Chair of Putnam’s Talent Committee. During his consulting career, Paul has assisted pharmaceutical and biotechnology companies in business development, R&D strategy, product valuations, product launch planning, market assessments, forecasting and global
Joseph serves major biopharmaceutical companies, developing strategies for pipeline agents, evaluating commercial opportunities, modeling detailed patient flows and treatment pathways, and optimizing plans for LCM/LOE. His clients span a wide range of therapeutic areas from oncology, cardiology, and hematology, to neurology and rheumatology, in addition to vaccines and diagnostics. Leveraging his experience with both pipeline
Scott Gilbert has served pharmaceutical and biotech clients across a wide range of specialty and primary care therapeutic areas in both domestic and international markets. Recent engagements have included pricing / managed markets strategy development, portfolio prioritization, medical adherence analysis, physician segmentation and opportunity analysis, and product forecasting. He has extensive expertise in advanced quantitative
John has been with Putnam Associates since 1992, and has over 21 years of strategy consulting experience. John has counseled senior executives at numerous leading pharmaceutical and biotechnology companies, providing strategic support and recommendations on a wide array of issues, including pricing, contracting and reimbursement strategies, corporate strategy, new product commercialization, clinical trial development, and
Remco specializes in helping life-sciences organizations develop global go-to-market and product lifecycle maximization strategies, addressing critical external stakeholder groups and leveraging internal functional expertise. He also serves as Putnam’s Boston Office Head. Since joining Putnam in 2000, Remco has served clients in the pharmaceutical, biotech and medical device industries on projects focused in both domestic
Matt serves leading clients within the life science industry on a range of commercial strategy issues. He has particular experience in helping his clients tackle complex challenges concerning pricing and market access strategy, product positioning and launch strategy, and market opportunity sizing and strategic direction setting. His practice is primarily focused in oncology, rare disease
Benjamin serves a range of life-science companies developing market opportunity assessments, global pricing and market access, therapeutic area, franchise, and product growth strategy, detailed forecasting, and market modeling. Benjamin has particular experience leading projects in oncology where he has mainly focused on both hematologic disorders (CML, MF, MM) and solid tumors (Pancreatic, Lung, Breast, and
Ryan serves leading biopharmaceutical and early stage life-science companies in strategic areas related to commercial opportunity assessment, pricing and market access strategy, and strategic marketing at the franchise and product level. He has broad experience working across client functional groups including marketing, finance, and medical affairs, across geographies with his extensive work in the EU,
I work with the partners, team, and clients to draw insights from primary and secondary data and provide strategies for supporting clinical and commercial development of pharmaceutical products.
77% of Putnam projects are serving clients who have trusted us with important projects 5 + years
I work at the interface of clients, partners, and the analytical team, managing all of the work that goes into bringing our clients the most bulletproof deliverables possible. The best part of working here is the opportunity to join teams with so many dedicated, whip-smart professionals solving very demanding problems every day.
My work at Putnam allows me dovetail my scientific and technical expertise with my business acumen. Additionally, Putnam takes a rigorous approach to problem solving and tackles complex and challenging problems that impact the global healthcare industry.
Collectively, Putnam employees speak a total of 22 languages
I enjoy the people I work with. Everyone brings a different style and essence to the team and watching it all come together is rewarding and fun
I recently rejoined Putnam as a Manager in the San Francisco office. It is an exciting opportunity to help grow the new office and work with our west coast clients
My projects at Putnam dig deeply at the science of many of the biggest drugs, and then pivots into identifying or analyzing for business opportunities within the context of the science.
Putnam has served 17 of the top 20 global biopharmaceutical companies since 2010
At Putnam, my role varies by project – but deep strategic analysis, laser focus on our clients’ goals, and sharp yet down-to-earth colleagues are all constants.
My role is exciting because it allows me to take on a wide range of different responsibilities from performing in-depth data analysis, to helping develop hypotheses and storylines for the overall project, to manage the workstreams of newer members of the team.
At Putnam, I am able to intertwine my knowledge and understanding of basic science with strategic business recommendations. I enjoy the complexity of the problems we solve and the process of solving them as teams.
Coming from the initial stages of drug discovery in academia, it’s exciting to learn the other end of the clinical pipeline and see how new therapies help patients. The best part of the job is the diversity, both in teams and projects.
My cases generally combine deep scientific understanding and rigorous quantitative analysis to profile current and future market implications for our clients. Our projects generally focus on paradigm-changing therapies facing complicated strategic challenges. It is quite invigorating working with our clients to help them redefine how a disease is treated.
94% of Putnam employees have worked on projects involving new products
Working at the intersection of science and business with the talented team at Putnam has made for an exciting and rewarding experience, and I look forward to working with new clients and facing new challenges every day.
Working at Putnam allows me to leverage my scientific and engineering background to solve complex problems that our clients face, while also getting to work with bright, driven, and interesting people.
Putnam has given me an incredible opportunity to navigate some of the most interesting challenges in the healthcare space while working alongside smart, diligent colleagues. I’ve been able to leverage my deep background in basic science and knowledge of business to tackle challenging problems across different therapeutic areas.
Putnam employees volunteer their time at over 24 different charitable organizations
The environment at Putnam is enriching and collaborative. I enjoy working with my colleagues to craft customized solutions to complex problems at every stage of the life sciences product lifecycle.
As a former bench scientist, I find it exciting to work on projects that involve cutting-edge technologies and breakthrough therapies that have a direct clinical impact. I am able to leverage my research expertise by providing scientific and analytical insight into the development of business strategies that help our clients tackle challenging problems.
Since 2000, more than 1/4 of Putnam Associates who have gone on to MBAs have attended HBS
Putnam is a fantastic place where everyone cares deeply about each other and the success of the team. As a Life Sciences Consultant, I’m often the scientific expert on my case team. I’ve leveraged my background experience and contributed from day one while learning new consulting and business skills.
I truly enjoy the work we do. My colleagues collaborate and openly share knowledge and ideas. Management selects and assigns complex (and interesting!) projects to teams to achieve best-in-class results. There’s opportunity to interact with our clients and engage them as strategic partners. Putnam is a great place to make an impact and professionally develop.
91% of Putnam employees have worked on a case looking at global markets
Coming from the pharmacy setting at the front line of patient care, it’s exciting to be involved with various aspects of the strategy behind novel agents. Every day presents new challenges to overcome, and having the opportunity to learn from brilliant individuals who are genuinely kind and helpful is what makes Putnam a great place
At Putnam, I get to leverage my in-depth knowledge of life sciences and my business acumen to tackle exciting and challenging problems within the healthcare industry, while working alongside brilliant individuals with a passion for problem solving.
Putnam fosters a collaborative environment where I combine deep commercial analysis with my passion for healthcare. From immunotherapy to gene therapy, my projects lie on the bleeding edge of healthcare and lead to meaningful impacts that I find invigorating.
Putnam was founded in 1988
My projects at Putnam vary greatly but all leverage complex problem solving to provide the best strategic recommendation to our client partners. Each project is a new opportunity for professional development and to take on increasing responsibility.
With fantastic people consistently delivering valuable insights to our client partners, it’s no surprise that Putnam is such a successful and steadily-growing firm. My teams at Putnam approach and tackle complex strategic challenges in the life sciences space from all angles; being part of this environment is exciting and motivating.
Coming from a Biology background, it is exciting to work at the forefront of the pharmaceutical world helping to inform impactful decisions for our clients. The collaborative and tight-knit team culture at Putnam ensure that every day is as exciting and rewarding as the day before as we pursue insightful answers to complex questions.
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.